Menu
Recruiting NCT06668519

Magnetoencephalography in Children

— Observational Epilepsy Intracranial Tumors Cerebrovascular Disease Autism

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Magnetoencephalography.
Who it may be relevant to
Registry conditions: Epilepsy, Intracranial Tumors, Cerebrovascular Disease, Autism. Basic parameters: 1 months — 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

An Observational Study on the Clinical Application of Magnetoencephalography in Children With Neurodevelopmental Disorders

Overview

This study is a single-center observational clinical study, which evaluates the diagnostic value of magnetoencephalography (MEG) in the diagnosis of neurodevelopmental diseases in children, such as the localization of epileptic foci and brain functional areas, intracranial tumors, cerebrovascular diseases, autism, mental retardation, and neuropsychiatric disorders.

Detailed description

The purpose of this study is to observe the application of magnetoencephalography (MEG) in pediatric neurodevelopmental disorders

Interventions

  • Other Magnetoencephalography
    Magnetoencephalography

Primary outcome measures

  • Difference in magnetoencephalography (MEG) signal between children with neurodevelopmental diseases and healthy children [Time frame: 3 years]

Eligibility criteria

Inclusion criteria

  • aged 1 month-18 years old (date of investigate minus date of birth)
  • epilepsy
  • intracranial tumors
  • cerebrovascular diseases
  • autism
  • mental retardation
  • ADHD
  • tic disorder
  • neuropsychiatric disorders

Exclusion criteria

1.Unable to cooperate with the exam of MEG

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

China · 1 center
  • Children's Hospital of Fudan University — Shanghai

Identifiers

NCT: NCT06668519 · 2024-173

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗